Dec 19 (Reuters) - AVITA Medical Inc RCEL.O :
- SUBMITS FDA PMA APPLICATION TO EXPAND INDICATION TO VITILIGO
- ANTICIPATE FULL LAUNCH OF THIS TREATMENT OPTION IN JANUARY 2025
- APPLICATION, IF APPROVED, WILL EXPAND THE INDICATION OF RECELL TO INCLUDE THE TREATMENT OF STABLE VITILIGO
News: AVH Avita Medical Inc Says Submits FDA PMA Application To Expand Indication To Vitiligo
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.100(7.46%) |
Mkt cap ! $106.0M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.49 | $1.41 | $1.139M | 782.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1682 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 1750 | 7 |
View Market Depth
| Last trade - 12.05pm 15/09/2025 (20 minute delay) ? |
| AVH (ASX) Chart |